Missouri Memory Center at Citizens Memorial Hospital participated in the Eli Lilly and Company international clinical trial of Donanemab, whose full results were shared Monday, July 17, at the 2023 Alzheimer's Association International Conference (AAIC) in Amsterdam, Netherlands, and simultaneously published in the Journal of the American Medical Association (JAMA).
This item is available in full to subscribers.
To continue reading, you will need to either log in to your subscriber account, below, or purchase a new subscription.
Please log in to continue
|